OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
2.280
-0.190 (-7.69%)
Nov 13, 2025, 4:00 PM EST - Market closed
OraSure Technologies Revenue
OraSure Technologies had revenue of $27.09M in the quarter ending September 30, 2025, a decrease of -32.14%. This brings the company's revenue in the last twelve months to $125.70M, down -43.95% year-over-year. In the year 2024, OraSure Technologies had annual revenue of $185.83M, down -54.17%.
Revenue (ttm)
$125.70M
Revenue Growth
-43.95%
P/S Ratio
1.35
Revenue / Employee
$250,904
Employees
501
Market Cap
163.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 185.83M | -219.65M | -54.17% |
| Dec 31, 2023 | 405.47M | 17.99M | 4.64% |
| Dec 31, 2022 | 387.48M | 153.81M | 65.82% |
| Dec 31, 2021 | 233.67M | 61.95M | 36.08% |
| Dec 31, 2020 | 171.72M | 17.12M | 11.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
OSUR News
- 8 days ago - OraSure Technologies, Inc. (OSUR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th - GlobeNewsWire
- 16 days ago - OraSure Technologies Appoints Steven K. Boyd to its Board of Directors - GlobeNewsWire
- 2 months ago - Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say - Reuters
- 2 months ago - Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid - Reuters
- 3 months ago - OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - OraSure Appoints Anne Messing as Chief Commercial Officer - GlobeNewsWire
- 3 months ago - OraSure Technologies: An Asymmetric Bet - Seeking Alpha